Year To Quarter End Consolidated Statement Of Comprehensive Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7730550

Concept 2017-03-01 to
2017-11-30
2016-03-01 to
2016-11-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
16,046,000,000 JPY
18,480,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
4,873,000,000 JPY
203,000,000 JPY
Foreign currency translation adjustment
-1,876,000,000 JPY
-8,950,000,000 JPY
Remeasurements of defined benefit plans, net of tax
197,000,000 JPY
300,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
44,000,000 JPY
-57,000,000 JPY
Other comprehensive income
3,239,000,000 JPY
-8,418,000,000 JPY
Comprehensive income
19,286,000,000 JPY
10,061,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
19,098,000,000 JPY
9,962,000,000 JPY
Comprehensive income attributable to non-controlling interests
187,000,000 JPY
99,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.